» Articles » PMID: 37745067

Association Between Marijuana Use and Kidney Stone: a Cross-sectional Study of NHANES 2009 to 2018

Overview
Journal Front Pharmacol
Date 2023 Sep 25
PMID 37745067
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this investigation is to determine whether regular marijuana use is related to history of kidney stones in the US population. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) from 2009 to 2018. Kidney stone and marijuana use data were collected from self-report questionnaires. Multivariate logistic regression and multiple sensitivity analyses were applied to examine the relationship between marijuana usage and kidney stones. There are approximately 26.04% of the US population have admitted to using marijuana in their lifetime. Compared with none regular users, those with a higher frequency of marijuana use were more males, more non-Hispanic races, lower than high school education, overweight, no recreational activity, without diabetes mellitus, and more coronary heart disease. After adjusting for potential confounders, multivariate regression analysis demonstrated that marijuana use was inversely correlated to kidney stones in males (Odds ratio [OR] = 0.72, 95% Confidence interval [CI] = 0.54-0.97). One to seven times/week regular consumption of marijuana was associated with kidney stones in males (OR = 0.62, 95% CI = 0.43-0.89). Sensitivity analyses validated the robustness of our outcomes. Our findings revealed that regular marijuana male users were inversely associated with kidney stones. Marijuana use one to six times/week was inversely related to the risk of kidney stones in males. Further studies are required to explore the dose and type associations of marijuana with kidney stones.

Citing Articles

Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation.

Mlynarska E, Kustosik N, Mejza M, Lyson Z, Delebis D, Orlinski J Nutrients. 2025; 17(1.

PMID: 39796493 PMC: 11722839. DOI: 10.3390/nu17010059.


Association between monocyte to high-density lipoprotein cholesterol ratio and kidney stone: insights from NHANES.

Wang Z, Zhao G, Cao Y, Gu T, Yang Q Front Endocrinol (Lausanne). 2024; 15:1374376.

PMID: 38894743 PMC: 11183274. DOI: 10.3389/fendo.2024.1374376.

References
1.
Di X, Liu S, Xiang L, Jin X . Association between the systemic immune-inflammation index and kidney stone: A cross-sectional study of NHANES 2007-2018. Front Immunol. 2023; 14:1116224. PMC: 9989007. DOI: 10.3389/fimmu.2023.1116224. View

2.
Heller H, Sakhaee K, Moe O, Pak C . Etiological role of estrogen status in renal stone formation. J Urol. 2002; 168(5):1923-7. DOI: 10.1016/S0022-5347(05)64264-4. View

3.
Di X, Gao X, Peng L, Ai J, Jin X, Qi S . Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. Signal Transduct Target Ther. 2023; 8(1):282. PMC: 10387486. DOI: 10.1038/s41392-023-01501-9. View

4.
Schisterman E, Cole S, Platt R . Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20(4):488-95. PMC: 2744485. DOI: 10.1097/EDE.0b013e3181a819a1. View

5.
Khan S, Canales B, Dominguez-Gutierrez P . Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 2021; 17(6):417-433. DOI: 10.1038/s41581-020-00392-1. View